The presence of increased circulating levels of TNFα and IL-6 in patients with cirrhosis without infections were described decades ago [80,81], but comprehensive characterization of these inflammatory mediators in AD cirrhosis and ACLF and their correlation with disease severity and organ failures were described more recently [4,5]. This evidence concerns the gene IL6 and infection.